Solid Historical Income Statement
| SLDB Stock | USD 8.98 0.44 5.15% |
Historical analysis of Solid Biosciences income statement accounts such as Other Operating Expenses of 81.4 M, Research Development of 60.6 M, Cost Of Revenue of 2.5 M or Total Operating Expenses of 81.1 M can show how well Solid Biosciences LLC performed in making a profits. Evaluating Solid Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Solid Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Solid Biosciences LLC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Solid Biosciences LLC is a good buy for the upcoming year.
Solid |
About Solid Income Statement Analysis
Solid Biosciences LLC Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Solid Biosciences shareholders. The income statement also shows Solid investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Solid Biosciences Income Statement Chart
Solid Biosciences LLC Income Statement is one of the three primary financial statements used for reporting Solid's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Solid Biosciences LLC revenue and expense. Solid Biosciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Solid Biosciences' Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 24.7 M, whereas Selling General Administrative is forecasted to decline to about 20.8 M. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Solid Biosciences LLC. It is also known as Solid Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Minority Interest
Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Solid Biosciences LLC whose combined shares represent less than 50% of the total outstanding shares issued by Solid Biosciences have a minority interest in Solid Biosciences.Most accounts from Solid Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Solid Biosciences LLC current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Solid Biosciences LLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. At present, Solid Biosciences' Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 24.7 M, whereas Selling General Administrative is forecasted to decline to about 20.8 M.
Solid Biosciences income statement Correlations
Click cells to compare fundamentals
Solid Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Solid Biosciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Income | 1.6M | 115K | 64K | 2.6M | 7.0M | 7.4M | |
| Selling General Administrative | 24.6M | 21.6M | 27.1M | 28.9M | 27.8M | 20.8M | |
| Gross Profit | (2.8M) | (3.9M) | (45.1M) | 5.7M | (2.6M) | (2.7M) | |
| Other Operating Expenses | 119.3M | 86.5M | 85.9M | 107.4M | 104.3M | 81.4M | |
| Operating Income | (119.3M) | (88.4M) | (72.3M) | (106.5M) | (104.3M) | (109.5M) | |
| Net Income From Continuing Ops | (117.2M) | (88.3M) | (72.2M) | (86.0M) | (90.8M) | (95.4M) | |
| Ebit | (119.3M) | (88.4M) | (72.3M) | (106.5M) | (104.3M) | (109.5M) | |
| Research Development | 94.7M | 64.9M | 58.7M | 78.4M | 76.6M | 60.6M | |
| Ebitda | (116.5M) | (80.6M) | (69.3M) | (107.9M) | (101.7M) | (106.8M) | |
| Cost Of Revenue | 2.8M | 3.9M | 58.7M | 2.4M | 2.6M | 2.5M | |
| Total Operating Expenses | 119.3M | 86.5M | 85.9M | 107.4M | 101.7M | 81.1M | |
| Income Before Tax | (117.2M) | (88.3M) | (72.2M) | (86.0M) | (96.0M) | (100.8M) | |
| Total Other Income Expense Net | 2.1M | 116K | 66K | 20.5M | 8.3M | 4.2M | |
| Net Income Applicable To Common Shares | (117.2M) | (88.3M) | (72.2M) | (86.0M) | (77.4M) | (81.3M) | |
| Net Income | (115.6M) | (90.1M) | (72.1M) | (65.5M) | (96.0M) | (100.8M) | |
| Income Tax Expense | (1.6M) | 1.8M | (64K) | (20.5M) | (18.4M) | (17.5M) | |
| Net Interest Income | 1.6M | 115K | 64K | 2.6M | 7.0M | 7.4M | |
| Depreciation And Amortization | 2.8M | 7.8M | 3.0M | (1.5M) | 2.6M | 2.3M | |
| Reconciled Depreciation | 2.8M | 3.9M | 3.0M | 2.4M | 2.9M | 2.7M |
Currently Active Assets on Macroaxis
When determining whether Solid Biosciences LLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Solid Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Solid Biosciences Llc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Solid Biosciences Llc Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Solid Biosciences LLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Solid Biosciences LLC information on this page should be used as a complementary analysis to other Solid Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Solid Stock analysis
When running Solid Biosciences' price analysis, check to measure Solid Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solid Biosciences is operating at the current time. Most of Solid Biosciences' value examination focuses on studying past and present price action to predict the probability of Solid Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solid Biosciences' price. Additionally, you may evaluate how the addition of Solid Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Solid Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solid Biosciences. If investors know Solid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Solid Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.83) | Quarterly Revenue Growth (1.00) | Return On Assets (0.31) | Return On Equity (0.57) |
The market value of Solid Biosciences LLC is measured differently than its book value, which is the value of Solid that is recorded on the company's balance sheet. Investors also form their own opinion of Solid Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Solid Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Solid Biosciences' market value can be influenced by many factors that don't directly affect Solid Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Solid Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Solid Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Solid Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.